0001213900-22-027983.txt : 20220518
0001213900-22-027983.hdr.sgml : 20220518
20220518172107
ACCESSION NUMBER: 0001213900-22-027983
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220517
FILED AS OF DATE: 20220518
DATE AS OF CHANGE: 20220518
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kaplan Myron
CENTRAL INDEX KEY: 0001672645
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34673
FILM NUMBER: 22940274
MAIL ADDRESS:
STREET 1: C/O KLEINBERG, KAPLAN, WOLFF & COHEN, PC
STREET 2: 551 FIFTH AVENUE, 18TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10176
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CorMedix Inc.
CENTRAL INDEX KEY: 0001410098
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 CONNELL DRIVE
STREET 2: SUITE 4200
CITY: BERKELEY HEIGHTS
STATE: NJ
ZIP: 07922
BUSINESS PHONE: 908-517-9500
MAIL ADDRESS:
STREET 1: 300 CONNELL DRIVE
STREET 2: SUITE 4200
CITY: BERKELEY HEIGHTS
STATE: NJ
ZIP: 07922
4
1
ownership.xml
X0306
4
2022-05-17
0
0001410098
CorMedix Inc.
CRMD
0001672645
Kaplan Myron
C/O CORMEDIX INC. 300 CONNELL
DRIVE, 300 CONNELL DRIVE, SUITE 4200
BERKELEY HEIGHTS
NJ
07922
1
0
0
0
Common Stock
2022-05-17
4
P
0
5000
3.78
A
160034
D
Common Stock
20000
I
Spouse
Common Stock
10000
I
Spouse as Guardian for Grandchildren
Stock Option (Right to Buy Common Stock)
4.03
2032-02-22
Common Stock
20000
20000
D
Stock Option (Right to Buy Common Stock)
8.32
2031-01-11
Common Stock
30000
30000
D
Stock Option (Right to Buy Common Stock)
5.63
2030-02-25
Common Stock
15000
15000
D
Stock Option (Right to Buy Common Stock)
8.3
2029-01-10
Common Stock
15000
15000
D
Stock Option (Right to(Right to Buy Common Stock)
2.85
2028-02-16
Common Stock
8000
8000
D
Stock Option (Right to Buy Common Stock)
11.2
2027-02-21
Common Stock
8000
8000
D
Stock Option (Right to Buy Common Stock)
21.4
2026-04-28
Common Stock
10000
1000
D
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.77 to $3.79,
inclusive. The reporting person undertakes to provide CorMedix Inc., any security holder of CorMedix Inc., or the staff of the Securities and Exchange
Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to
this Form 4.
The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the
beneficial owner of the securities for purposes of Section 16 or for any other purpose.
These options were granted on 2/22/2022. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued
service on the board.
These options were granted on 1/11/2021. These options are fully vested.
These options were granted on 2/25/2020. These options are fully vested.
These options were granted on 1/10/2019. These options are fully vested.
These options were granted on 2/16/2018. These options are fully vested.
These options were granted on 2/21/2017. These options are fully vested.
These options were granted on 4/28/2016. These options are fully vested.
/s/ Myron Kaplan
2022-05-18